PD-L1 and Tumor Infiltrating Lymphocytes as Prognostic Markers in Resected NSCLC.

Cited by papers we hold 3

• The Interplay between MicroRNAs and Cellular Components of Tumour Microenvironment (TME) on Non-Small-Cell Lung Cancer (NSCLC) Progression · 2019
  No notice
• PD-L1 expression in lung cancer and its correlation with driver mutations: a meta-analysis · 2017
  No notice
• Expression of PD-L1 and prognosis in breast cancer: a meta-analysis · 2017
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.